# Mosaic Co: overview

MOS · NYSE · CIK 1285785 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mos.md) · [Financials](/companies/mos/financials.md) · [Filings](/companies/mos/filings.md) · [Insiders](/companies/mos/insiders.md)

Latest reported revenue: [$2.82bn](/filings/0001285785-26-000112.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001285785-26-000112).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,811](/filings/0001628280-25-049494.md) | [2,816 d](/filings/0001285785-26-000017.md) | [2,621](/filings/0001285785-26-000067.md) | [3,006](/filings/0001285785-26-000112.md) | [3,452](/filings/0001628280-25-049494.md) | [2,974 d](/filings/0001285785-26-000017.md) | [2,998](/filings/0001285785-26-000067.md) | [2,824](/filings/0001285785-26-000112.md) |
| Gross margin | % | [14.8%](/filings/0001628280-25-049494.md) | [10.7% d](/filings/0001285785-26-000017.md) | [18.6%](/filings/0001285785-26-000067.md) | [17.3%](/filings/0001285785-26-000112.md) | [16.0%](/filings/0001628280-25-049494.md) | [11.5% d](/filings/0001285785-26-000017.md) | [7.9%](/filings/0001285785-26-000067.md) | [7.6%](/filings/0001285785-26-000112.md) |
| Operating margin | % | [4.1%](/filings/0001628280-25-049494.md) | [3.5% d](/filings/0001285785-26-000017.md) | [12.9%](/filings/0001285785-26-000067.md) | [8.1%](/filings/0001285785-26-000112.md) | [9.8%](/filings/0001628280-25-049494.md) | [(3.4%) d](/filings/0001285785-26-000017.md) | [(12.4%)](/filings/0001285785-26-000067.md) | [(1.3%)](/filings/0001285785-26-000112.md) |
| Net margin | % | [4.3%](/filings/0001628280-25-049494.md) | [6.0% d](/filings/0001285785-26-000017.md) | [9.1%](/filings/0001285785-26-000067.md) | [13.7%](/filings/0001285785-26-000112.md) | [11.9%](/filings/0001628280-25-049494.md) | [(17.5%) d](/filings/0001285785-26-000017.md) | [(8.6%)](/filings/0001285785-26-000067.md) | [(9.7%)](/filings/0001285785-26-000112.md) |
| Diluted EPS | $ per share | [0.38](/filings/0001628280-25-049494.md) | not reported | [0.75](/filings/0001285785-26-000067.md) | [1.29](/filings/0001285785-26-000112.md) | [1.29](/filings/0001628280-25-049494.md) | not reported | [(0.81)](/filings/0001285785-26-000067.md) | [(0.86)](/filings/0001285785-26-000112.md) |
| Free cash flow | $m | [72.1 d](/filings/0001628280-25-049494.md) | [(74.8) d](/filings/0001285785-26-000017.md) | [(298)](/filings/0001285785-26-000067.md) | [305 d](/filings/0001285785-26-000112.md) | [(136) d](/filings/0001628280-25-049494.md) | [(406) d](/filings/0001285785-26-000017.md) | [(253)](/filings/0001285785-26-000067.md) | [(153) d](/filings/0001285785-26-000112.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [12.4](/filings/0001618034-24-000004.md) | [19.1](/filings/0001618034-25-000003.md) | [13.7](/filings/0001285785-26-000017.md) | [11.1](/filings/0001285785-26-000017.md) | [12.1](/filings/0001285785-26-000017.md) |
| Gross margin | % | [25.9%](/filings/0001618034-24-000004.md) | [30.1%](/filings/0001618034-25-000003.md) | [16.1%](/filings/0001285785-26-000017.md) | [13.6%](/filings/0001285785-26-000017.md) | [15.8%](/filings/0001285785-26-000017.md) |
| Operating margin | % | [20.0%](/filings/0001618034-24-000004.md) | [25.0%](/filings/0001618034-25-000003.md) | [9.8%](/filings/0001285785-26-000017.md) | [5.6%](/filings/0001285785-26-000017.md) | [6.8%](/filings/0001285785-26-000017.md) |
| Net margin | % | [13.2%](/filings/0001618034-24-000004.md) | [18.7%](/filings/0001618034-25-000003.md) | [8.5%](/filings/0001285785-26-000017.md) | [1.6%](/filings/0001285785-26-000017.md) | [4.5%](/filings/0001285785-26-000017.md) |
| Diluted EPS | $ per share | [4.27](/filings/0001618034-24-000004.md) | [10.06](/filings/0001618034-25-000003.md) | [3.50](/filings/0001285785-26-000017.md) | [0.55](/filings/0001285785-26-000017.md) | [1.70](/filings/0001285785-26-000017.md) |
| Free cash flow | $bn | [0.9](/filings/0001618034-24-000004.md) | [2.7](/filings/0001618034-25-000003.md) | [1.0](/filings/0001285785-26-000017.md) | [0.0](/filings/0001285785-26-000017.md) | [(0.5)](/filings/0001285785-26-000017.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mos/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $524.5m | 24,751,481 |  | Added +1,104,511 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $439.6m | 20,744,667 |  | Added +109,328 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $387.6m | 18,292,494 |  | Added +7,367,770 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $318.7m | 15,039,070 |  | Added +1,631,423 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $315.8m | 14,904,222 |  | Added +3,667,101 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $312.8m | 14,759,347 |  | Reduced −546,006 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $305.4m | 14,411,407 |  | Added +171,357 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $279.7m | 13,199,733 |  | Reduced −15,879,277 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $188.7m | 8,919,117 |  | Added +167,591 |
| [DONALD SMITH & CO., INC.](/funds/814375.md) | 2026-06-30 | $163.7m | 7,723,547 |  | Added +3,105,856 |

## Recent filings

[All 1,513 filings](/companies/mos/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-25 | 23:04 ET | [8-K](/filings/0001285785-26-000125.md) | 5.02 Departure or appointment of officers or directors | 0001285785-26-000125 |
| 2026-08-28 | 20:09 ET | [8-K](/filings/0001285785-26-000122.md) | 2.04 Item not in the standard list | 0001285785-26-000122 |
| 2026-08-17 | 20:18 ET | [8-K](/filings/0001193125-26-354095.md) | 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-354095 |
| 2026-08-17 | 10:38 ET | [8-K](/filings/0001193125-26-353193.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-353193 |
| 2026-08-14 | 20:25 ET | [8-K](/filings/0001193125-26-352365.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-352365 |
| 2026-08-10 | 12:50 ET | [8-K](/filings/0001193125-26-341391.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-341391 |
| 2026-08-05 | 18:20 ET | [10-Q](/filings/0001285785-26-000112.md) | Quarterly report, period 2026-06-30 | 0001285785-26-000112 |
| 2026-08-04 | 20:26 ET | [8-K](/filings/0001285785-26-000109.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001285785-26-000109 |
| 2026-06-15 | 16:34 ET | [8-K](/filings/0001285785-26-000093.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001285785-26-000093 |
| 2026-05-29 | 18:18 ET | [8-K](/filings/0001285785-26-000069.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001285785-26-000069 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001285785-26-000017.md), filed Feb 27, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/fe50095f-e013-4f3e-a934-2c48c059f9ab)

## About the filer

- CIK: 1285785
- Tickers: MOS
- Exchange: NYSE
- SIC code: 2870 Agricultural Chemicals
- State of incorporation: not reported
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.